Display options
Cite
Friedman JM. The use of dysmorphology in birth defects epidemiology. Teratology. 1992;45(2):187-93doi: 10.1002/tera.1420450212.
Friedman, J. M. (1992). The use of dysmorphology in birth defects epidemiology. Teratology, 45(2), 187-93. https://doi.org/10.1002/tera.1420450212
Friedman, J M. "The use of dysmorphology in birth defects epidemiology." Teratology vol. 45,2 (1992): 187-93. doi: https://doi.org/10.1002/tera.1420450212
Friedman JM. The use of dysmorphology in birth defects epidemiology. Teratology. 1992 Feb;45(2):187-93. doi: 10.1002/tera.1420450212. PMID: 1615428.
Copy Download .nbib Format: NLM
Share it on

Teratology. 1992 Feb;45(2):187-93. doi: 10.1002/tera.1420450212.

The use of dysmorphology in birth defects epidemiology.

Teratology

J M Friedman

Affiliations

  1. Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

PMID: 1615428 DOI: 10.1002/tera.1420450212

Abstract

Most human teratogens have been identified by the clinical recognition of characteristic patterns of congenital anomalies among children whose mothers were exposed to a particular agent during pregnancy. Although this dysmorphologic method has been valuable, it is criticized because it is not easily amenable to statistical evaluation. Conventional birth defects epidemiological studies are designed to permit rigorous statistical assessment, but such investigations usually classify congenital anomalies without adequate consideration of their known etiological heterogeneity. It is possible to combine the best aspects of these two approaches to identifying human teratogens in a "dysmorphologic case/control study." Instead of including all available cases with a given defect, only individuals having the anomaly in the context of a multiple congenital anomaly pattern without a recognizable cause would be selected for inclusion among the case group. The frequency of exposure to the putative teratogen would be determined among these selected cases and among appropriately chosen controls; conventional statistical analysis would then be performed. Although this design reduces the size of the case group compared to a conventional case/control study, the statistical power is unchanged or increased. In addition, biological plausibility is increased by concentrating upon a group of cases that is more likely to have a teratogenic cause.

Similar articles

Carmichael SL.
Eur J Med Genet. 2014 Aug;57(8):355-8. doi: 10.1016/j.ejmg.2014.03.002. Epub 2014 Mar 19.
PMID: 24657225

Cited by

MeSH terms

Publication Types

LinkOut - more resources